Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: KVUE )

22.52 -0.41 (-1.77%)
Streaming Delayed Price Updated: 2:15 PM EDT, Oct 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,397,116
Open 22.82
Bid (Size) 22.52 (9)
Ask (Size) 22.53 (49)
Prev. Close 22.93
Today's Range 22.52 - 22.95
52wk Range 17.67 - 23.55
Shares Outstanding N/A
Dividend Yield 0.89%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Analysts Have This To Say About Kenvue
Via Benzinga
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
The activist investor says Pfizer has underperformed its peers and the broader market since 2019. 
Via Investor's Business Daily

Performance

YTD
+4.43%
+4.43%
1 Month
-2.15%
-2.15%
3 Month
+25.63%
+25.63%
6 Month
+16.29%
+16.29%
1 Year
+14.46%
+14.46%

More News

Read More
Nvidia Among Five Best S&P 500 Stocks Today
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Dow Drops 320 Points as Stocks Cool Off
Via Talk Markets
Topics Stocks
Exposures US Equities
What's Going On With Kenvue Stock Monday?
Via Benzinga
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
Via Benzinga
Navigating 10 Analyst Ratings For Kenvue
Via Benzinga
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Activist Investor Starboard Acquires Stake In Band-Aid Maker Kenvue, Shares Jump
Via Talk Markets
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Via Benzinga
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
From Kenvue
Via Business Wire
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
P/E Ratio Insights for Kenvue
Via Benzinga
There are signs that NYSE:KVUE may be ready to breakout.
Via Chartmill
Analyst Ratings For Kenvue
Via Benzinga
Johnson & Johnson Stock: Setting the Stage for 2025 Highs
Via MarketBeat
Exposures COVID-19
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Via The Motley Fool
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Via Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Via Benzinga
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Via The Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Donald Trump Owns These 21 Dividend Kings. Should You?
Via The Motley Fool
Topics Government
Exposures Political
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.